Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion
Merck KGaA has agreed to acquire life sciences company Bio-Techne Corporation for $11.3bn, representing one of the largest financial outlays…
Merck KGaA has agreed to acquire life sciences company Bio-Techne Corporation for $11.3bn, representing one of the largest financial outlays…
With pharma and medtech Q1 earnings season now at a close, some sector areas performed better than others. In this…
With the leadership role of the US Food and Drug Administration (FDA) vacant following Marty Makary’s resignation earlier this week,…
For 30-year-old office worker Jay, Neko Health offered the chance to peek into a window of her health. “I initially…
With the full-year 2025 earnings season coming to a close, certain sectors in healthcare performed strongly against the industry average.…
Roche’s adjusted operating profit rose by a lower-than-expected 5% in 2025, due to the weakened US dollar, despite the drugmaker…
The Gates Foundation and OpenAI are launching a $50m initiative to roll out artificial intelligence (AI) across countries in Africa…
This year's J.P. Morgan Healthcare Conference wrapped up without the usual high level of M&A we've grown accustomed to. Boston…
Eli Lilly and NVIDIA will establish a new artificial intelligence (AI) co-innovation lab, as the companies look to use each…
As the healthcare industry embarks on a new year, there are several factors that look set to impact pharmaceutical and…